Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Tirzepatide is FDA-approved
Despite their initial promise, GLP-1 receptor agonists may not provide a sustainable solution for cardiovascular health improvement
8 The combination of high drug costs and a large patient population may have profound implications for employers overall health care spend
Lukes Medical Center often tailor GLP-1 regimens based on lab work, lifestyle, and diet patterns common in the local population
US$ 23.88
US$ 29.56
US$ 25.93
US$ 23.30
